{"id":1742,"date":"2013-01-20T00:00:00","date_gmt":"2013-01-20T00:00:00","guid":{"rendered":"http:\/\/www.neurodegenerationresearch.eu\/2013\/01\/lilly-gets-go-ahead-for-alzheimers-diagnostic-in-eu\/"},"modified":"2014-09-22T09:13:58","modified_gmt":"2014-09-22T09:13:58","slug":"lilly-gets-go-ahead-for-alzheimers-diagnostic-in-eu","status":"publish","type":"post","link":"https:\/\/neurodegenerationresearch.eu\/he\/2013\/01\/lilly-gets-go-ahead-for-alzheimers-diagnostic-in-eu\/","title":{"rendered":"Lilly gets go ahead for alzheimers diagnostic in EU"},"content":{"rendered":"

Eli Lilly has been granted approval in the EU for Amyvid, a solution to diagnose Alzheimer's disease.<\/strong><\/p>\n

Amyvid (florbetapir [18F]) is used as an imaging agent during positron emission tomography (PET) scanning to detect the presence or absence of beta-amyloid plaques in the brains of adult patients with cognitive impairment.
&nbsp;
At the moment, doctors rely only on a clinical evaluation to decide whether patients with cognitive impairment are suffering from Alzheimer's disease or some other cause of cognitive decline, so being able to see whether amyloid plaques are present in the brain will help the accuracy of diagnosis. <\/p>\n

More information at the link below:<\/p>\n","protected":false},"excerpt":{"rendered":"

Eli Lilly has been granted approval in the EU for […]<\/p>\nView Post<\/a>","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[22],"tags":[],"class_list":["post-1742","post","type-post","status-publish","format-standard","hentry","category-research-news"],"acf":[],"yoast_head":"\nLilly gets go ahead for alzheimers diagnostic in EU - JPND Neurodegenerative Disease Research<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/neurodegenerationresearch.eu\/2013\/01\/lilly-gets-go-ahead-for-alzheimers-diagnostic-in-eu\/\" \/>\n<meta property=\"og:locale\" content=\"he_IL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lilly gets go ahead for alzheimers diagnostic in EU - JPND Neurodegenerative Disease Research\" \/>\n<meta property=\"og:description\" content=\"Eli Lilly has been granted approval in the EU for […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/neurodegenerationresearch.eu\/2013\/01\/lilly-gets-go-ahead-for-alzheimers-diagnostic-in-eu\/\" \/>\n<meta property=\"og:site_name\" content=\"JPND Neurodegenerative Disease Research\" \/>\n<meta property=\"article:published_time\" content=\"2013-01-20T00:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2014-09-22T09:13:58+00:00\" \/>\n<meta name=\"author\" content=\"jpnd\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@JPNDeurope\" \/>\n<meta name=\"twitter:site\" content=\"@JPNDeurope\" \/>\n<meta name=\"twitter:label1\" content=\"\u05e0\u05db\u05ea\u05d1 \u05e2\u05dc \u05d9\u05d3\" \/>\n\t<meta name=\"twitter:data1\" content=\"jpnd\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u05d6\u05de\u05df \u05e7\u05e8\u05d9\u05d0\u05d4 \u05de\u05d5\u05e2\u05e8\u05da\" \/>\n\t<meta name=\"twitter:data2\" content=\"\u05d3\u05e7\u05d41\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/2013\\\/01\\\/lilly-gets-go-ahead-for-alzheimers-diagnostic-in-eu\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/2013\\\/01\\\/lilly-gets-go-ahead-for-alzheimers-diagnostic-in-eu\\\/\"},\"author\":{\"name\":\"jpnd\",\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/#\\\/schema\\\/person\\\/a97e49cae588ead81db59e48a4e63c2a\"},\"headline\":\"Lilly gets go ahead for alzheimers diagnostic in EU\",\"datePublished\":\"2013-01-20T00:00:00+00:00\",\"dateModified\":\"2014-09-22T09:13:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/2013\\\/01\\\/lilly-gets-go-ahead-for-alzheimers-diagnostic-in-eu\\\/\"},\"wordCount\":115,\"publisher\":{\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/#organization\"},\"articleSection\":[\"Research News (General)\"],\"inLanguage\":\"he-IL\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/2013\\\/01\\\/lilly-gets-go-ahead-for-alzheimers-diagnostic-in-eu\\\/\",\"url\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/2013\\\/01\\\/lilly-gets-go-ahead-for-alzheimers-diagnostic-in-eu\\\/\",\"name\":\"Lilly gets go ahead for alzheimers diagnostic in EU - JPND Neurodegenerative Disease Research\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/#website\"},\"datePublished\":\"2013-01-20T00:00:00+00:00\",\"dateModified\":\"2014-09-22T09:13:58+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/2013\\\/01\\\/lilly-gets-go-ahead-for-alzheimers-diagnostic-in-eu\\\/#breadcrumb\"},\"inLanguage\":\"he-IL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/neurodegenerationresearch.eu\\\/2013\\\/01\\\/lilly-gets-go-ahead-for-alzheimers-diagnostic-in-eu\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/2013\\\/01\\\/lilly-gets-go-ahead-for-alzheimers-diagnostic-in-eu\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Lilly gets go ahead for alzheimers diagnostic in EU\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/#website\",\"url\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/\",\"name\":\"JPND Neurodegenerative Disease Research\",\"description\":\"Neurodegenerative Disease Research\",\"publisher\":{\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"he-IL\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/#organization\",\"name\":\"JPND\",\"url\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"he-IL\",\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.neurodegenerationresearch.eu\\\/wp-content\\\/uploads\\\/2022\\\/03\\\/logo.png\",\"contentUrl\":\"https:\\\/\\\/www.neurodegenerationresearch.eu\\\/wp-content\\\/uploads\\\/2022\\\/03\\\/logo.png\",\"width\":248,\"height\":129,\"caption\":\"JPND\"},\"image\":{\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/JPNDeurope\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/#\\\/schema\\\/person\\\/a97e49cae588ead81db59e48a4e63c2a\",\"name\":\"jpnd\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"he-IL\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b3244fc6099279fad29cb751cb709c5ee57befcda19ef0b44a4f0067989d7f7e?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b3244fc6099279fad29cb751cb709c5ee57befcda19ef0b44a4f0067989d7f7e?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b3244fc6099279fad29cb751cb709c5ee57befcda19ef0b44a4f0067989d7f7e?s=96&d=mm&r=g\",\"caption\":\"jpnd\"},\"url\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/he\\\/author\\\/jpnd\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Lilly gets go ahead for alzheimers diagnostic in EU - JPND Neurodegenerative Disease Research","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/neurodegenerationresearch.eu\/2013\/01\/lilly-gets-go-ahead-for-alzheimers-diagnostic-in-eu\/","og_locale":"he_IL","og_type":"article","og_title":"Lilly gets go ahead for alzheimers diagnostic in EU - JPND Neurodegenerative Disease Research","og_description":"Eli Lilly has been granted approval in the EU for […]","og_url":"https:\/\/neurodegenerationresearch.eu\/2013\/01\/lilly-gets-go-ahead-for-alzheimers-diagnostic-in-eu\/","og_site_name":"JPND Neurodegenerative Disease Research","article_published_time":"2013-01-20T00:00:00+00:00","article_modified_time":"2014-09-22T09:13:58+00:00","author":"jpnd","twitter_card":"summary_large_image","twitter_creator":"@JPNDeurope","twitter_site":"@JPNDeurope","twitter_misc":{"\u05e0\u05db\u05ea\u05d1 \u05e2\u05dc \u05d9\u05d3":"jpnd","\u05d6\u05de\u05df \u05e7\u05e8\u05d9\u05d0\u05d4 \u05de\u05d5\u05e2\u05e8\u05da":"\u05d3\u05e7\u05d41"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/neurodegenerationresearch.eu\/2013\/01\/lilly-gets-go-ahead-for-alzheimers-diagnostic-in-eu\/#article","isPartOf":{"@id":"https:\/\/neurodegenerationresearch.eu\/2013\/01\/lilly-gets-go-ahead-for-alzheimers-diagnostic-in-eu\/"},"author":{"name":"jpnd","@id":"https:\/\/neurodegenerationresearch.eu\/#\/schema\/person\/a97e49cae588ead81db59e48a4e63c2a"},"headline":"Lilly gets go ahead for alzheimers diagnostic in EU","datePublished":"2013-01-20T00:00:00+00:00","dateModified":"2014-09-22T09:13:58+00:00","mainEntityOfPage":{"@id":"https:\/\/neurodegenerationresearch.eu\/2013\/01\/lilly-gets-go-ahead-for-alzheimers-diagnostic-in-eu\/"},"wordCount":115,"publisher":{"@id":"https:\/\/neurodegenerationresearch.eu\/#organization"},"articleSection":["Research News (General)"],"inLanguage":"he-IL"},{"@type":"WebPage","@id":"https:\/\/neurodegenerationresearch.eu\/2013\/01\/lilly-gets-go-ahead-for-alzheimers-diagnostic-in-eu\/","url":"https:\/\/neurodegenerationresearch.eu\/2013\/01\/lilly-gets-go-ahead-for-alzheimers-diagnostic-in-eu\/","name":"Lilly gets go ahead for alzheimers diagnostic in EU - JPND Neurodegenerative Disease Research","isPartOf":{"@id":"https:\/\/neurodegenerationresearch.eu\/#website"},"datePublished":"2013-01-20T00:00:00+00:00","dateModified":"2014-09-22T09:13:58+00:00","breadcrumb":{"@id":"https:\/\/neurodegenerationresearch.eu\/2013\/01\/lilly-gets-go-ahead-for-alzheimers-diagnostic-in-eu\/#breadcrumb"},"inLanguage":"he-IL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/neurodegenerationresearch.eu\/2013\/01\/lilly-gets-go-ahead-for-alzheimers-diagnostic-in-eu\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/neurodegenerationresearch.eu\/2013\/01\/lilly-gets-go-ahead-for-alzheimers-diagnostic-in-eu\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/neurodegenerationresearch.eu\/"},{"@type":"ListItem","position":2,"name":"Lilly gets go ahead for alzheimers diagnostic in EU"}]},{"@type":"WebSite","@id":"https:\/\/neurodegenerationresearch.eu\/#website","url":"https:\/\/neurodegenerationresearch.eu\/","name":"JPND Neurodegenerative Disease Research","description":"Neurodegenerative Disease Research","publisher":{"@id":"https:\/\/neurodegenerationresearch.eu\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/neurodegenerationresearch.eu\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"he-IL"},{"@type":"Organization","@id":"https:\/\/neurodegenerationresearch.eu\/#organization","name":"JPND","url":"https:\/\/neurodegenerationresearch.eu\/","logo":{"@type":"ImageObject","inLanguage":"he-IL","@id":"https:\/\/neurodegenerationresearch.eu\/#\/schema\/logo\/image\/","url":"https:\/\/www.neurodegenerationresearch.eu\/wp-content\/uploads\/2022\/03\/logo.png","contentUrl":"https:\/\/www.neurodegenerationresearch.eu\/wp-content\/uploads\/2022\/03\/logo.png","width":248,"height":129,"caption":"JPND"},"image":{"@id":"https:\/\/neurodegenerationresearch.eu\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/JPNDeurope"]},{"@type":"Person","@id":"https:\/\/neurodegenerationresearch.eu\/#\/schema\/person\/a97e49cae588ead81db59e48a4e63c2a","name":"jpnd","image":{"@type":"ImageObject","inLanguage":"he-IL","@id":"https:\/\/secure.gravatar.com\/avatar\/b3244fc6099279fad29cb751cb709c5ee57befcda19ef0b44a4f0067989d7f7e?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/b3244fc6099279fad29cb751cb709c5ee57befcda19ef0b44a4f0067989d7f7e?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b3244fc6099279fad29cb751cb709c5ee57befcda19ef0b44a4f0067989d7f7e?s=96&d=mm&r=g","caption":"jpnd"},"url":"https:\/\/neurodegenerationresearch.eu\/he\/author\/jpnd\/"}]}},"_links":{"self":[{"href":"https:\/\/neurodegenerationresearch.eu\/he\/wp-json\/wp\/v2\/posts\/1742","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/neurodegenerationresearch.eu\/he\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/neurodegenerationresearch.eu\/he\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/neurodegenerationresearch.eu\/he\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/neurodegenerationresearch.eu\/he\/wp-json\/wp\/v2\/comments?post=1742"}],"version-history":[{"count":0,"href":"https:\/\/neurodegenerationresearch.eu\/he\/wp-json\/wp\/v2\/posts\/1742\/revisions"}],"wp:attachment":[{"href":"https:\/\/neurodegenerationresearch.eu\/he\/wp-json\/wp\/v2\/media?parent=1742"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/neurodegenerationresearch.eu\/he\/wp-json\/wp\/v2\/categories?post=1742"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/neurodegenerationresearch.eu\/he\/wp-json\/wp\/v2\/tags?post=1742"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}